Assessing the construct validity of aberrant salience

Frontiers in Behavioral Neuroscience

Volumn 3, Issue DEC, 2009, Pages

  Schmidt, Kristin ^a   Roiser, Jonathan P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aberrant salience; Attention; Construct validity; Factor analysis; Learned irrelevance; Probabilistic reward learning; Schizotypy

Indexed keywords

EID: 78651288483     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/neuro.08.058.2009     Document Type: Article

References (53)

1. Baruch, I., Hemsley, D. R., and Gray, J. A. (1988). Differential performance of acute and chronic schizophrenics in a latent inhibition task. J. Nerv. Ment. Dis. 176, 598-606.
2. Bedwell, J. S., Kamath, V., and Compton, M. T. (2009). The relationship between interview-based schizotypal personality dimension scores and the continuous performance test. Schizophr. Res. 108, 158-162.
3. Berridge, K. C., and Robinson, T. E. (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res. Brain Res. Rev. 28, 309-369.
4. Braunstein-Bercovitz, H. (2003). The modulation of latent inhibition by field-dependency: is it related to attentional dysfunction in schizotypy? Pers. Individ. Dif. 35, 1719-1729.
5. Braunstein-Bercovitz, H., and Lubow, R. E. (1998). Are high-schizotypal normal participants distractible or limited in attentional resources? A study of latent inhibition as a function of masking task load and schizotypy level. J. Abnorm. Psychol. 107, 659-670.
6. Claridge, G. (1994). Single indicator of risk for schizophrenia: probable fact or likely myth? Schizophr. Bull. 20, 151-168.
7. Cohen, J. D., Barch, D. M., Carter, C., and Servan-Schreiber, D. (1999). Contextprocessing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks. J. Abnorm. Psychol. 108, 120-133.
8. Corlett, P. R., Honey, G. D., and Fletcher, P. C. (2007). From prediction error to psychosis: ketamine as a pharmacological model of delusions. J. Psychopharmacol. (Oxford) 21, 238-252.
9. De la Casa, L. G., Ruiz, G., and Lubow, R. E. (1993). Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: implications for schizophrenia. Biol. Psychiatry 33, 707-711.
10. Gal, G., Mendlovic, S., Bloch, Y., Beitler, G., Levkovitz, Y., Young, A. M., Feldon, J., and Ratzoni, G. (2005). Learned irrelevance is disrupted in first-episode but not chronic schizophrenia patients. Behav. Brain Res. 159, 267-275.
11. Gold, J. M., Waltz, J. A., Prentice, K. J., Morris, S. E., and Heerey, E. A. (2008). Reward processing in schizophrenia: a deficit in the representation of value. Schizophr. Bull. 34, 835-847.
12. Gray, J. A. (1998). Integrating Schizophrenia. Schizophr. Bull. 24, 249-266.
13. Gray, J. A. (2004). [Letter to the Editor.]. Am. J. Psychiatry 161, 377.
14. Gray, J. A., Feldon, J., Rawlins, J. N. R., Hemsley, D. R., and Smith, A. D. (1991). The neuropsychology of schizophrenia. Behav. Brain Res. 14, 1-20.
15. Gray, N. S., Fernandez, M., Williams, J., Ruddle, R. A., and Snowden, R. J. (2002). Which schizotypal dimensions abolish latent inhibition? Br. J. Clin. Psychol. 41, 271-284.
16. Gray, N. S., Pilowsky, L. S., Gray, J. A., and Kerwin, R. W. (1995). Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr. Res. 17, 95-107.
17. Heerey, E. A., Bell-Warren, K. R., and Gold, J. M. (2008). Decision-making impairments in the context of intact reward sensitivity in schizophrenia. Biol. Psychiatry 64, 62-69.
18. Hemsley, D. R. (1993). A simple (or simplistic?) cognitive model for schizophrenia. Behav. Res. Ther. 31, 633-645.
19. Horvitz, J. C. (2000). Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 96, 651-656.
20. Jensen, J., and Kapur, S. (2009). Salience and psychosis: moving from theory to practise. Psychol. Med. 39, 197-198.
21. Jensen, J., Willeit, M., Zipursky, R. B., Savina, I., Smith, A. J., Menon, M., Crawley, A. P., and Kapur, S. (2008). The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology 33, 473-479.
22. Jones, S. H., Gray, J. A., and Hemsley, D. R. (1992). Loss of the Kamin blocking effect in acute but not chronic schizophrenics. Biol. Psychol. 32, 739-755.
23. Kapur, S. (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am. J. Psychiatry 160, 13-23.
24. Keri, S., Kelemen, O., Szekeres, G., Bagoczky, N., Erdelyi, R., Antal, A., Benedek, G., and Janka, Z. (2000). Schizophrenics know more than they can tell: probabilistic classification learning in schizophrenia. Psychol. Med. 30, 149-155.
25. Laruelle, M., and Abi-Dargham, A. (1999). Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J. Psychopharmacol. (Oxford) 13, 358-371.
26. Lubow, R. E., and De la Casa, G. (2002). Latent inhibition as a function of schizotypality and gender: implications for schizophrenia. Biol. Psychol. 59, 69-86.
27. Maher, B. A. (1974). Delusional thinking and perceptual disorder. J. Individ. Psychol. 30, 98-113.
28. Mason, O., Linney, Y., and Claridge, G. (2005). Short scales for measuring schizotypy. Schizophr. Res. 78, 293-296.
29. Miller, R. (1976). Schizophrenic psychology, associative learning and the role of forebrain dopamine. Med. Hypotheses 2, 203-211.
30. Murray, G. K., Clark, L., Corlett, P. R., Blackwell, A. D., Cools, R., Jones, P. B., Robbins, T. W., and Poustka, L. (2008a). Incentive motivation in firstepisode psychosis: a behavioural study. BMC Psychiatry 8, 34.
31. Murray, G. K., Corlett, P. R., Clark, L., Pessiglione, M., Blackwell, A. D., Honey, G., Jones, P. B., Bullmore, E. T., Robbins, T. W., and Fletcher, P. C. (2008b). Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol. Psychiatry 13, 239, 267-276.
32. Orosz, A. T., Feldon, J., Gal, G., Simon, A. E., and Cattapan-Ludewig, K. (2008). Deficient associative learning in drugnaive first-episode schizophrenia: results obtained using a new visual within-subjects learned irrelevance paradigm. Behav. Brain Res. 193, 101-107.
33. Robbins, T. W. (2005). Synthesizing schizophrenia: a bottom-up, symptomatic approach. Schizophr. Bull. 31, 854-864.
34. Rogers, R. D., Blackshaw, A. J., Middleton, H. C., Matthews, K., Hawtin, K., Crowley, C., Hopwood, A., Wallace, C., Deakin, J. F., Sahakian, B. J., and Robbins, T. W. (1999). Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology (Berl.) 146, 482-491.
35. Rogers, R. D., Tunbridge, E. M., Bhagwagar, Z., Drevets, W. C., Sahakian, B. J., and Carter, C. S. (2003). Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28, 153-162.
36. Roiser, J. P., Stephan, K. E., den Ouden, H. E., Barnes, T. R., Friston, K. J., and Joyce, E. M. (2009). Do patients with schizophrenia exhibit aberrant salience? Psychol. Med. 39, 199-209.
37. Schmidt-Hansen, M., Killcross, A. S., and Honey, R. C. (2009). Latent inhibition, learned irrelevance, and schizotypy: assessing their relationship. Cogn. Neuropsychiatry 14, 11-29.
38. Seeman, P., and Kapur, S. (2000). Schizophrenia: more dopamine, more D2 receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 7673-7675.
39. Shaner, A. (1999). Delusions, superstitious conditioning and chaotic dopamine neurodynamics. Med. Hypotheses 53, 119-123.
40. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., and Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl 20), 22-33;quiz 34-57.
41. Shrira, A., and Tsakanikos, E. (2009). Latent inhibition as a function of positive and negative schizotypal symptoms: evidence for a bidirectional model. Pers. Individ. Dif. 47, 434-438.
42. Solomon, P. R., Crider, A., Winkelman, J. W., Turi, A., Kamer, R. M., and Kaplan, L. J. (1981). Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: Relationship to schizophrenic attention disorder. Biol. Psychol. 16, 519-537.
43. Swainson, R., Rogers, R. D., Sahakian, B. J., Summers, B. A., Polkey, C. E., and Robbins, T. W. (2000). Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38, 596-612.
44. Vaitl, D., Lipp, O., Bauer, U., Schuler, G., Stark, R., Zimmermann, M., and Kirsch, P. (2002). Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophr. Res. 55, 147-158.
45. Verdoux, H., and van Os, J. (2002). Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr. Res. 54, 59-65.
46. Waltz, J. A., and Gold, J. M. (2007). Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr. Res. 93, 296-303.
47. Waltz, J. A., Schweitzer, J. B., Gold, J. M., Kurup, P. K., Ross, T. J., Salmeron, B. J., Rose, E. J., McClure, S. M., and Stein, E. A. (2009). Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology 34, 1567-1577.
48. Wechsler D. (1981). Manual for the Wechsler Adult Intelligence Scale-Revised. New York, NY, The Psychological Corporation.
49. Wechsler, D. (2001). Wechsler Test of Adult Reading manual. San Antonio, TX, The Psychological Corporation.
50. Weiner, I., Lubow, R. E., and Feldon, J. (1981). Chronic amphetamine and latent inhibition. Behav. Brain Res. 2, 285-286.
51. Weiner, I., Lubow, R. E., and Feldon, J. (1984). Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmocology 83, 194-199.
52. Weiner, I., Lubow, R. E., and Feldon, J. (1988). Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol. Biochem. Behav. 30, 871-878.
53. Young, A. M., Kumari, V., Mehrotra, R., Hemsley, D. R., Andrew, C., Sharma, T., Williams, S. C., and Gray, J. A. (2005). Disruption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI. Behav. Brain Res. 156, 277-288.